Pharmacy Friends

This year marks the second AMCP Annual meeting where Prime and MRx have showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.  

We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry. 

Four of the Prime/MRx studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime/MRx has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime/MRx, here to walk us through the research.

We’re about to hear about an award-winning research study. Recently, a number of generic multiple sclerosis medications supported by the American Academy of Neurology have become more widely available. Managed care pharmacists can aid individuals in transitioning to generic therapies, reducing total drug spend and member cost. But just how successful can this transition be? Prime/MRx researchers took a closer look, and Nick Friedlander, clinical program pharmacist with Prime/MRx, explains how transition may lead to remarkable savings and improved health outcomes.

A key aspect of what AMCP seeks to achieve is improved access to care, and our next study looks closely at the factors that may impact that access. Social determinants of health are the conditions in a person’s environment that affect health, function, and quality-of-life outcomes and risks. These factors contribute to as much as 80% of variation in health outcomes. In this segment, Kyle Thompson, data scientist principal with Prime/MRx, talks about how the development of a Medicare member-specific medication nonadherence risk score, related to social determinants of health, can improve how a member manages medication and adheres to their doctors prescription. 

The mission of the Academy of Managed Care Pharmacy is to enhance the quality and affordability of health care. Prime/MRx is likewise focused on this same mission, which is even more crucial when you consider a key category driving health care spend today are specialty drugs, which are typically injections or infusions that are self-administered or administered by health care professionals.  We caught up with Kristen Reimers, clinical pharmacist and senior vice president, Specialty Clinical Solutions at Prime/MRx, to talk about some of the education sessions at AMCP that touch on this important business segment.

Nothing might matter more than getting new talented and bright pharmacists in our door to get hands-on experience of specialty and medical drug management from a managed care perspective. YuQian Liu, Senior Director of Clinical Account Services, talks about how our ASHP accredited residency program allows people interested in managed care pharmacy to build their careers. She talks about the importance of developing a firsthand understanding of medical and pharmacy benefit integration and strategy. And touches on the skills and mindset needed that helps kick-start careers as a managed care pharmacist. 

In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime/Magellan Rx, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it’s impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered. 

Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen. More about our company - https://www.primetherapeutics.com/

Newsroom - https://www.primetherapeutics.com/news/

Making pharmacy’s future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/

Join Prime - https://www.primetherapeutics.com/careers/

Discover how the brightest minds in oncology are illuminating the possibilities. Listen to Simone Ndujiuba, Oncology Clinical Strategy, and Innovation Director, and Dr. Joseph Leach Chief Medical Officer at Prime Therapeutics and Medical Oncologist at the University of Minnesota Physicians, join forces to discuss next-generation trends, cutting-edge technologies, and their captivating journey of becoming oncologists.

*Prime Therapeutics does not practice medicine.

Hosted by Brian MacDonald, director of specialty clinical strategy at Magellan Rx Management, and joined by Kourteney Martinez, pharmacy engagement specialist at Blue Cross Blue Shield of Alabama.

Jonathan Magness, vice president of Medicare Part D operations sits down with Mark Santilli, senior director of clinical strategy and programs, to talk managed care, the future of pharmacy, and more!

Jonathan Magness, vice president of Medicare Part D operations sits down with Alaka'i Montalbo, senior manager of formulary management, to talk managed care, the future of pharmacy, and more!

We are diving into all things 340B on this episode. Julie Burns, our resident consultant healthcare whiz is joined by Kevin Denton, a certified 340B expert and pharmacy programs mastermind at Magellan Rx. Listen to this episode to learn about 340B and hear some fun, facts, and mythbusters.

Pharmacy Friends Podcast is coming soon!